Hypertrophy Regression with N-Acetylcysteine in Hypertrophic Cardiomyopathy
Protocol #: HSC-MS-10-0533
Account #: B216
This study is currently RECRUITING.
Ali Marian M.D.
SLEH Estimated Enrollment:
Drug: N-acetylcysteine (NAC)
Objective & Purpose:
The purpose of the sudy is to conduct a small study to gather the preliminary data for future large scale clinical studies that will be designed to test the potential beneficial efffect of over-the counter study anti-oxidant drug called N-acetylcysteine (NAC) in patients with a heart muscle condition called Hypertrophic Cardiomyopathy (HCM). The present study is a pilot feasibility study, the investigators want to find out whether the investigators can recruit and retain patients with HCM in the study and whether these patients can tolerate this drug and can stay on for one year. Likewise, the investigators want to find out any potential side effects that this drug might have and estimate whether it has any beneficial effects.
Please refer to this study by its IRB#: HSC-MS-10-0533